Arcus Biosciences

RCUSNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$3.304 B

$25.95 +2.81%

Close of 21 Sept 2026

Revenue

$247.0M

#2216 by revenue

Earnings

-$353.0M

Loss-making

Shares outstanding

127,333,376

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#71Enliven TherapeuticsELVN$3.58B
#72Viking TherapeuticsVKTX$3.51B
#73Arcus BiosciencesRCUS$3.30B
#74Arcutis BiotherapeuticsARQT$3.26B
#75Dyne TherapeuticsDYN$3.20B

What if Arcus Biosciences were worth as much as…

Open the what-if tool →

Gold $30.3T

$237,754.27

Per share 9,162× higher

Bitcoin $1.72T

$13,506.31

Per share 520× higher

Nvidia $5.48T

$43,035.52

Per share 1,658× higher

Or at a round number

$5.00B $10.0B $20.0B $50.0B

Where these numbers come from

Share counts and financials for Arcus Biosciences are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.